Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature.
This review aimed to identify, synthesize, and analyze the findings of studies on proteomic biomarkers for spontaneous preterm birth (PTB). Three electronic databases (Medline, Embase, and Scopus) were searched for studies in any language reporting the use of proteomic biomarkers for PTB published between January 1994 and December 2012. Retrieved citations were screened, and relevant studies were selected for full-text reading, in triplicate. The search yielded 529 citations, 51 were selected for full-text reading and 8 studies were included in the review. A total of 64 dysregulated proteins were reported. Only 14-3-3 protein sigma, annexin A5, protein S100-A8, protein S100-A12, and inter-α-trypsin inhibitor heavy chain H4 were reported in more than 1 study, but results could not be combined due to heterogeneity in type of sample and analytical platform. In conclusion, according to the existing literature, there are no specific proteomic biomarkers capable of accurately predicting PTB.
1Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Marian
M
Kacerovsky
Juraj
J
Lenco
Ivana
I
Musilova
Vojtech
V
Tambor
Ronald
R
Lamont
Maria Regina
MR
Torloni
Ramkumar
R
Menon
D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D047928:Premature Birth / Q000175:diagnosis* / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*
D015415:Biomarkers
preterm delivery; proteomic; systematic review